Monoclonal antibodies specific for T cell-associated carbohydrate determinants react with human blood group antigens CAD and SDA by unknown
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The mAbs CT 1 and CT2 were obtained in a screen for antibodies reacting
with the murine CTL clone B3.3 and are able to block specific target cell lysis
by this and other CTL clones (1). The analysis of a large panel of cytotoxic and
helper T cell clones showed that Lyt-2' CTL clones invariably expressed very
high levels ofCT antigens, whereas all helper T cell clones either did notexpress
or only weakly expressed the CT determinants (1, 2) . In vivo, the only mature
T cells that express CT antigens are Lyt-2+ intraepithelial lymphocytes of the
intestinal mucosa (3, 4), thus suggesting that these antigens may be restricted to
the Lyt-2+ subset . However, the CT determinants are expressed on fetal thy-
mocytes in a developmentally regulated fashion with high levels of CT antigen
expressed early in fetal thymus ontogeny, followed by a gradual decrease in CT
antigen expression as birth approaches (5). The relationship between the pres-
ence of CT antigens in the fetal thymus and peripheral T cell populations is not
yet known . It is also evident from the differing tissue and cell specificities of the
CT1 and CT2 mAbs that these reagents recognize similar but not identical
determinants . Although a functional role for theCT carbohydrate determinants
has not yet been described, recent results in other systems indicate an intrinsic
role for cell type-specific oligosaccharides during development (reviewed in
references 6, 7) .
Biochemical analysis showed that CT I immunoprecipitates surface glycopro-
teins of the T200 family and additional, unrelated glycoproteins of 140 and 85
kD, as well as a secreted glycoprotein of 155 kD from biosynthetically labeled
CTL clones (2, 8) . Although forms of the T200 glycoprotein are found on all
hematopoietic cells except cells of the erythroid lineage, the CT I antigen was
expressed only on the T200 glycoprotein of activated CTL in vitro (1, 2) . The
CT1 and CT2 antibodies bind to distinct but overlapping epitopes since CT1
blocks binding of CT2 to clone B3.3 efficiently, but the reverse is not true (2) .
The fact that the CT antigens are present on several unrelated glycoproteins
and are destroyed by sodium periodate, coupled with the finding that during
biosynthesis of T200, the CTI antigen is acquired late, i.e ., after the N-linked
oligosaccharides become resistant to endoglycosidase H, suggested that the CT
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determinants required carbohydrate for expression (8). Moreover, the data
suggested that 0-linked carbohydrates could carryCT 1 antigen since the secreted
155-kD glycoprotein synthesized in the presence of tunicamycin was immuno-
precipitated by the CT 1 antibody. However, the precise carbohydrate residues
required for CT antigen expression have not yet been defined.
Previously, the GaINAc-specific lectin from Vicia villosa (VV)' was shown
to react specifically with CTL but not helper-type lymphocytes (9-11). The
biochemical analysis of the murine CTL clone B6.1 shows that it binds the
VVB4 isolectin and that the binding sites consist of a variety of 0-linked
structures which after desialylation, range from di- to hexasaccharides and
carry /3-linked Ga1NAc residues at their nonreducing termini (12). The small-
est of these structures was found to be related to a structure previously de-
scribed on glycophorin A from erythrocytes of the rare human blood Cad,
namely GalNAc#I-4(NeuAca2-3)Gal,#l-3(NeuAca2-6)-GalNAca1-Ser/Thr(13).
B6.1 .VV6, a mutant selected for resistance to the toxic effects of the VV lectin
is deficient in VV binding sites, lacks these terminal Ga1NAc residues, and is
deficient in a UdP-Ga]NAc: a-galactose (31,4-N-acetylgalactosaminyltransferase
(11, 12, 14). Using this cell line as well as several other criteria we have defined
the requisite oligosaccharide configuration necessary for CT antigen expression.
We find that the CT determinants are similarto thehuman blood group antigens
Cad and Sda.
Materials and Methods
Cells.
￿
The origin of B6.1, B6 .1 .VV6, and B3 .3 cell lines have been described (1, 11).
Fresh Cad and thawed Tn erythrocytes were kindly donated by Dr. J . P. Cartron (Centre
National de Transfusion Sanguine, Paris, France). The Cad erythrocytes were from the
original Cad individual whose glycophorin A contains #1,4-linked Ga1NAc on 12 of 15 of
its 0-linked oligosaccharides (15). A, and Az erythrocytes (16) were obtained through the
local blood bank and O, A, AB, and B erythrocytes were taken from healthy volunteers
using citrate for anticoagulation. All cells were washed four times in PBS before they
were used in agglutination assays.
Agglutination Assays. Agglutination assays were performed in Nunclon Microwell
plates (72 x 10 p1, Gibco Laboratories, Basel, Switzerland). Antibodies and cells were
diluted in PBS, 1 mM CaC12, and 2 mg/ml BSA. We added 2 y1 of cell suspension
containing about 10'cells or 104 erythrocytes to 4 j1 of diluted antibody. The plates were
then incubated for 45 min at 6°C in a humidified atmosphere on a clinical rotator
operating at 80 rpm. The plates were scored under the inverted microscope. Purified
VV4 lectin was the kind gift of Dr. S. Tollefsen, Washington University, St. Louis, MO.
Solid-Phase Radioimmunoassay. Purified Sda+ or Sda- Tamm-Horsfall glycoproteins
were kindly given to us by Dr. W. Watkins, Clinical Research Center, Harrow, United
Kingdom . The glycoproteins were diluted in PBS and added to 96-well polyvinyl micro-
titer plates (Dynatech Laboratories Inc ., Alexandria, VA) at 30 Al per well; after incubation
for 30 min at room temperature in a humidified atmosphere, the remaining sites were
blocked by adding 200 ul/ml of PBS with 2 mg/ml BSA. This buffer was used through
the following steps. After incubation at room temperature for 5 min, the wells were
washed two times (200,ul/well/wash), received 50 y1 of antibody containing ascites diluted
as indicated, were incubated at room temperature for 30 min or as indicated, washed
three times, and were subsequently incubated with affinity-purified rabbit anti-mouse
IgG radiolabeled with '2r'I by the Iodogen method. Each well received 3 x 105 cpm of
antibody with a specific activity of ^-0.1 uCi/Ag in 80 pl. After incubation at 4°C for 1 h
' Abbreviation used in this paper:
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or as indicated, plates were washed seven times and individual wells were cut from the
plate with scissors to be counted in a gamma counter . Desialylation of bovine submaxillary
mucin (Sigma Chemical Co ., St . Louis, MO) was performed as described (17) and the
release of sialic acid was followed by the method ofWarren (18) .
Glycosidase Treatment.
￿
CTL clones were lysed with ice-cold 1% NP-40 in PBS contain-
ing 100 Kallikrein units of aprotinin/ml (Sigma Chemical Co .) and 2mM PMSF (Behring
Diagnostics, La Jolla, CA) . Extracts were centrifuged at 50,000 g for 30 min . 10,ul of the
lysate equivalent to 10' cells was then incubated for 18 h at 37°C with or without the
addition of glycosidases . Buffers and enzyme concentrations used were as follows ; endo-
glycosidase F (N-glycanase ; Genzyme Corp ., Boston, MA) 50 U/ml, 0.17% SDS, 0.2 M
sodium phosphate, 10 mM 1,10-phenanthroline hydrate, 1 .25% NP-40, pH 8.6 ; neura-
minidase (V. cholerae, Gibco Laboratories ; Cl . perfringens Type X, Sigma Chemical Co .),
0.05 M sodium-acetate, pH 5.5, with 9 mg NaCl/ml and 1 mg CaC11/ml . In some cases
the neuraminidase inhibitor 2-3-dehydro-2-deoxy-N-acetylneuraminic acid (Boehringer
Mannheim Biochemicals, Indianapolis, IN) was added from 1 to 10 mM .
Western Blotting .
￿
After treatment of lysates with glycosidases or with buffer alone, the
samples were subjected to acetone precipitation at -20°C for 24 h . The samples were
centrifuged at 13,000 g for 30 min, the pellets were resuspended in 50 JAI of PBS
containing aprotinin and PMSF, and duplicate samples (25 Al each) were dot-blotted onto
nitrocellulose . The nitrocellulose was dried and nonspecific binding was blocked by
overnight incubation in BLOTTO (19). The strip was then incubated for 2 h at room
temperature with 20 ml of a 1 :200 dilution in BLOTTO ofCTI ascites fluid . The strip
was washed three times over a 1 h period followed by incubation for 1 h with 20 ml of a
1 :500 dilution of rabbit anti-mouse Ig (Cappel Laboratories, Cochranville, PA) . After
washing, 2 x 105 cpm/ml 125I-labeled protein A from Staphylococcus aureus (ICN Biomed-
icals, Irvine, CA) was added for 1 h followed by washing and drying of the strip . The
blots were cut out and the amount of radioactivity bound was measured in a gamma
counter .
Periodate Treatment and Fluorescence Analysis.
￿
Intact CTL clones were incubated for
45 min at 4°C in the dark with increasing concentrations (1-4 mM) of sodium-m-periodate
(Sigma Chemical Co .) dissolved in PBS (20) . The cells were then washed with PBS
containing 1 mg/ml BSA and 0.1% NaN3 . The cells were incubated for 30 min with CT 1,
CT2, or 13/2.3 (a rat mAb reactive with the mouse T200 glycoprotein [21]) . After
washing, the cells were reacted with fluorescein-labeled goat anti mouse-Ig (for CTI and
CT2) or a goat anti rat-Ig (Cappel) . Single cells were analyzed by fluorescence flow
cytometry on a FRCS IV (Becton Dickinson & Co ., Sunnyvale, CA) .
Results
Interaction of CTI and CT2 with the CTL Line B6.1 and its VV-resistant Mu-
tants . We wished to determine whether B6 .1 expressed the CT antigens and
whether the CT antigens were retained on the cell surface after VV selection .
Since the CT mAbs are of the IgM isotype, we used their ability to agglutinate
CT' cells to determine expression . CTI and CT2 mAbs both strongly agglutin-
ated the CTL line B6.1 but did not agglutinate the B6 .I.VV6 mutant tine . This
line had 100-fold less binding sites for VV than the B6.1 line when assayed with
a crude VV preparation containing both the A and B isolectins (Fig . 1) (11) .
Two other VV-resistant mutants, B6 .1.VV3 and B6 .1.VV4, that still expressed
high numbers of VV binding sites (11) were agglutinated by CTI and CT2 to
the same extent as the parental line . As expected, VVB4 lectin only agglutinated
B6.1 but not the B6.LVV6 mutant . These findings are consistent with the idea
that the terminal ß-1,4-linked GaINAc residues that are lacking in the B6.1.VV6
mutant are an essential component of the determinant(s) recognized by CT 1 and
CT2 .122
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FIGURE l .
￿
Agglutination of CTL line B6 .1 and
VV-resistant mutants . ForCT 1 and CT2, we used
ascites fluid as stock solution for the dilutions (as-
cites usually contains 1-5mg/mlofantibody) . The
stock of VVB4 lectin was 500 lag/ml . Bars range
from the lowest to the highest dilution resulting in
strong agglutination . In the absence of agglutina-
tion, the highest antibody concentration tested is
indicatedby a vertical line .
FIGURE 2 .
￿
Binding of CT1 and CT2 to Tamm-Horsfall gly-
coprotein in solid-phase RIA . (A) Sda' (closed symbols) or Sda-
(open symbols) Tamm-Horsfall glycoproteinswere used at varying
concentrations to coat polyvinyl plates . Subsequently, a fixed
amount of antibody (ascites, diluted 1 :100) was added. Bound
CT antibody was then detected with radiolabeled second anti-
body . (B) plates were coated with Sda' Tamm-Horsfall glycopro-
tein at 10,ug/ml and subsequently incubated with varying dilu-
tions ofantibody . Points represent the mean of duplicate assays .
Standard deviations are indicated by bars if they amounted to
more than 2% . CTI (O, "); CT2 (E], ") ; F.F6 (A) ; F.F6 is an
unrelated mAb used as a control .
Binding ofCTI and CT2 toHuman Blood Group Sda+ Antigen .
￿
Although found
in the ganglioside series of glycolipids, GaINAc-linked /31,4 to galactose is not
commonly found on glycoproteins . Glycophorin A from red blood cells of the
rare human blood group Cad contains terminal /31,4-linked Ga1NAc on some of
its 0-linked oligosaccharides (Table I) (13, 15) . The determinant is also present
on Tamm-Horsfall urinary glycoprotein of Sda+ individuals whereas the same
glycoprotein lacks GaINAc residues in Sda- individuals (22-24) . Thus, binding
of CT1 and CT2 to Tamm-Horsfall glycoproteins was assessed by solid-phase
RIA. As shown in Fig . 2, both antibodies bound to the Sda+ but not to the Sda-
glycoprotein . The specific binding was dependent on the amount of Sda'NT,not tested .
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TABLE I
Reactivity ofCT mAb with Human Blood Group Structures
glycoprotein attached to the plate, whereas no such dose-dependent binding
could be detected with theSda glycoprotein . Titration curves ofboth antibodies
were similar and binding was detectable at 50,000-fold diluted ascites (Fig . 2B) .
At plateau levels, -100 ng of '25I-labeled rabbit anti-mouse Ig were specifically
bound . This binding could not be blocked by the addition of 0.2 M GaINAc to
the reaction . Thus, it was likely that the CTI and CT2 mAb recognized the
Ga1NAco1,4[SAa2,3]Gal determinant . Moreover, the determinant appears to be
recognized independently of the protein core to which it is attached and suggests
that the CT determinants can be carried by N-linked oligosaccharides, since
Tamm-Horsfall glycoproteins are believed not to contain 0-linked oligosaccha-
rides (22) .
Interaction ofCTI and CT2 with Cad Erythrocytes.
￿
CTI and CT2 were tested
as agglutinins of erythrocytes of type A, B, O, Cad, and Tn which carry the
antigenic carbohydrate determinants depicted in Table I . As illustrated by Fig.
3, we did not observe any agglutination of A, B, O, or Tn erythrocytes whereas
Cad cells were strongly agglutinated . ^-95% of Cad cells were agglutinated
indicating that the CT I and CT2 determinants were carried by most cells. The
VVB4 isolectin agglutinated Cad as well as Tn, but not A, erythrocytes (25) . To
ensure that the nonagglutinated erythrocytes were not binding subagglutinating
concentrations of mAbs, type A, B, or O erythrocytes were used to absorb a
limiting amount of CTI mAb. After absorption, the unbound antibody was
quantitated by the solid-phase RIA on Sda+ Tamm-Horsfall glycoprotein . Eryth-
rocytes from A, B, or 0 donors did not absorb any CT 1 antibody at 3 x 109
Structure Origin
CT
reac-
tivity
VVB4
reac-
tivity
GalNacal-3Gal,Q1-3/4GIcNAc Blood group A - -
al-2 I al-4
Fuc Fuc
Galal-3GA01-3/4GIcNAc Blood group B - -
al-2 I al-4
Fuc Fuc
Gal,B1-3/4GIcNAc Blood groupO - -
I al-2 I al-4
Fuc Fuc
Golf l-3GaINAcal-Ser/Thr
a2-3 I a2-6 Main 0-linked structure ofglyco- - -
SA SA phorin A
GaINAcal-Ser/Thr Main O-linked structure of glyco- - +
phorin A in Tn erythrocytes (32)
Ga1NAcfl1-4Galgl-3GaINAca1-Ser/Thr Main O-linked structure of glyco- + +
a2-3 I a2-6 phorin A in Cad erythrocytes (8)
SA SA
GaINAc,B1-4Gal~1-4GIcNAc#1-3Gal- . . . Sda + pentasaccharide from + NT
a2-3 Tamm-Horsfall glycoprotein (13)
SA124
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FIGURE 3 .
￿
Agglutination of erythrocytes by CT 1
and CT2. (Dark bars) heavy agglutination; (light
bars) agglutination of part of the cells into small
clumps (two to six erythrocytes) . (Stippled areas)
loose aggregates observed . (1) Experiment was
done at room temperature . (2) The A donor in
Exp . I was not typed as A, orA2 (17) .
cells/ml, whereas Cad erythrocytes absorbed the antibody completely (data not
shown) . Furthermore, significant binding of the CT mAbs to type A, B, or O
erythrocytes was not detected using fluorescence flow cytometry (data not
shown) .
The fact that CT1 and CT2 did not agglutinate Tn erythrocytes suggested
that they were unable to bind to GANAcal-Ser/Thr structures (Fig . 3) . This
was confirmed by using native and desialylated bovine submaxillary mucin as an
inhibitor in the RIA on Sda+ Tamm-Horsfall glycoprotein . Bovine submaxillary
mucin contains SAa2-6Ga]NAc al-Ser/Thr as the predominant 0-linked oligo-
saccharide structure . 50% inhibition of the binding of CT1 and CT2 to Sda+
Tamm-Horsfall glycoprotein by the Sda+ glycoprotein was achieved at 3.8 x
10-7 and 10-' M, respectively (molarities in terms ofGa1NAc residues), whereas
the desialylated bovine submaxillary mucin required 1,400-fold (CT1) or 350-
fold (CT2) higher concentrations (data not shown) . Moreover, since there was
no difference in the inhibitory capacity between native and desialylated mucin
we conclude that the CT1 antibody does not react with the Ga1NAcal-Ser/Thr
structure . The results thus far strongly suggested that the CT determinants were
contained within the unique oligosaccharide structure found on Cad erythrocytes
(Table I) . This was confirmed by the demonstration that the CT mAbs react
with purified Cad' gangliosides (Cartron,J. P., personal communication) .
Requirementfor Sialic Acid in CT Determinants .
￿
To determine if sialic acid wasó
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TABLE II
Effect ofSialidase Treatments on CTI Reactivity
Enzyme
Neuraminidase(V. cholerae)
(10 U/ml)
Neuraminidase(CI. perfringens)
(5 U/ml)
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FIGURE 4. Requirement for sialic acid in CTI deter-
minants. Aliquots of deterent lysate made from CTL
cloneB3.3 (equivalent to 101 cells) were incubated for 18
h at 37'C with neuraminidase at the indicatedconcentra-
tions ("). The neuraminidase inhibitor, 2-3-dehydro-2-
deoxy-N-acetylneuraminic acid, was added at 1 mM (O)
or 10 mM (A). Afterincubation, thesampleswere acetone
precipitated and the resulting material was dot-blotted
onto nitrocellulose followed by detection using CTI
mAb, rabbit anti-mouse IgG and '25I-labeled protein A.
Cells
Control binding
Exp. 3
8
Aliquots ofdetergent lysate (100 Al, equivalent to 106lymphocytes or 2 x
10' erythrocytes) were incubated for 18 h at 37 °C with or without the
addition of sialidases. After acetone precipitation, the resulting material
wasdot-blotted onto nitrocellulose followed by detectionusingCT 1, rabbit
anti-mouse IgGand'25I-protein A. Numbers in parentheses indicate the
binding of CT1 after enzyme treatments performed in the presence of
the neuraminidase inhibitor, 2-3-dehydro-2-deoxy-N-acetylneuraminic
acid, addedto 10 InM.
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involved in the antigenic determinant recognized by the CT antibodies, we
treated cell lysates from CTL clone B3.3 with neuraminidase and quantitated
the remaining CT1 reactivity using a dot-blot assay. The CT2 antigen could not
be assessed because the CT2 mAb is extremely inefficient in Western blotting.
Initially, neuraminidase from V. cholerae was used and proved ineffective at
altering CT binding (see Table II). However, when neuraminidase from C.
perfringens was used, nearly complete abrogation of CTI binding was achieved
(Fig. 4; Table II). To insure that neuraminidase activity was the activity being
measured in these assays, the neuraminidase inhibitor, 2-3-dehydro-2-deoxy-N-
acetylneuraminic acid was added to the reaction. As is shown in Fig. 4, a
concentration of 1 InM ofthis inhibitor greatly reduced the removal ofthe CT1
determinant and a concentration of 10 mM of the inhibitor completely blocked
removal ofCT1 antigen by C. perfringens neuraminidase. Thus, sialic acidappears
to be an integral part of the CTI antigenic determinant in clone B3.3.
It has previously been demonstrated that terminal, unsubstituted sialic acid
Exp. I Exp. 2
B3.3 86 82
B3.3 11(95) 11 (93)
B6.1 2(89) 3
Cad 20(94) 15126
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TABLE III
Periodate Sensitivity ofCT Antigens on CTL Clone 86.1
and CadErythrocytes
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FIGURE 5.
￿
Positions 7 to 9 of sialic acid are important for
CT determinants. Intact CTL clones were incubated at 4°C
in thedark with ImM or 4mM sodium-m-periodatedissolved
in PBS. The cells were then reacted with CT I (A) or CT2
(B) and subsequently stained with FITC-labeled goat anti-
mouse IgG. Individual cells were analyzed by fluorescence
flow cytometry. Stippled line : untreated cells with secondary
antibody only .
Cells were periodate treated as described in Fig. 5 and stained with CTI
and CT2mAb followed by FITC-labeled rabbit anti-mouse IgG. Individ-
ual cellswere analyzed by fluorescence flow cytometry . Numbers represent
mean fluorescence intensity per cell on an arbitrary linear scale .
can be selectively oxidized between the exocyclic 7-,8- and 9-hydroxyl positions
by low concentrations ofperiodate under mild conditions (20, 26, 27). However,
if the sialic acid has an acetyl group at positions 8 or 9, this reaction is blocked
(28, 29) . We used mild periodate treatment to find out if positions 7 to 9 of sialic
acid were necessary for the binding of theCT antibodies . Results for clone B3.3
are shown in Fig . 5 and for clone B6.1 in Table III. Treatment of intact CTL
clones with I mM periodate significantly reduced CTI binding and nearly
completely abrogated the binding of CT2, indicating that sialic acid was also
required for formation of the CT2 determinant . Increasing the concentration
of periodate to 4 mM further reduced CTI binding, while CT2 exhibited little
binding above background after this treatment . In Cad erythrocytes binding of
both antibodies was nearly completely abolished by treatment with I mM
periodate. The binding ofmAbs against the T200 glycoprotein (which bears the
CT determinants of CTL clones) was not affected by these treatments (data not
Cells Periodate pre-
treatment
CTI CT2
mM
B6 .1 None 122 185
1 116 29
4 48 5
Cad None 11 11
1 0.7 0.5
4 0.3 0.16CONZELMANN AND LEFRANCOIS
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shown) . This result indicates that positions 7 to 9 of the sialic acid involved in
the CT determinant are important for the binding of these antibodies . In
addition, periodate treatment affected CT2 binding more readily than CT1
binding . Endoglycosidase F, when added to a lysate of B3.3 cells did not affect
the subsequent binding of the CT1 antibody, although immunoprecipitation of
endoglycosidase F-treated [35S]methionine-labeled material showed a significant
reduction in apparent molecular weight of the CT1-reactive proteins (data not
shown) . This suggested that the CT1 determinant is not present on N-linked
glycans on B3 .3 cells.
Discussion
This study demonstrated that the CT I and CT2 mAbs react with the
GaINAc#1,4-[SAa2,3]Gal carbohydrate determinant . Three independent
sources containing ,81,4-linked GaINAc residues were recognized by the CT
mAb: the murine CTL-clone B6.1, the human blood group Cad antigen, and
theTamm-Horsfall urinary glycoprotein from Sda+individuals. The correspond-
ing sources that lacked the GaINAc residue (B6.1.VV6, non-Cad erythrocytes,
Sda- glycoprotein) did not bind these antibodies . Sialic acid was an integral part
of the antigenic structure as well, since sialidase from C. perfringens destroyed
theCT I antigens ofB3 .3 cells, whereas sialidase from V . cholerae was ineffective .
It appeared likely that the antigenic sialic acid was attached to the subterminal
galactose residue (see Table I), since sialic acid in this position is resistant to V .
cholerae but not C. perfringens sialidase (30) and since on Sda+ Tamm-Horsfall
glycoprotein no other sialic acid is present in the vicinity of the ,81,4-linked
GaINAc residue . The destruction of CT antigens by mild periodate oxidation
further demonstrated the importance of sialic acid for the CT determinants .
The structures recognized by theCT mAb were periodate-sensitive both in CTL
clones and Cad erythrocytes . Since the conditions used here for periodate
treatment have been shown to result in oxidation only between the exocyclic 7-,
8-, and 9-hydroxyl positions of terminal, unsubstituted sialic acid residues (19,
25, 26), it appeared that these positions were important for CT mAb binding .
It is possible that, onCTL clones, theCT mAbs also recognize other O-linked
oligosaccharides, since on the B6.1 CTL line the Cad oligosaccharide was only
found as one component among several O-linked structures that all carried #-
linked GaINAc residues at their nonreducing terminus (12) . Although isolated
in their desialized form, all these structures probably carried sialic acids in their
native form since the UdP-GaINAc:o-galactose ,81,4-N-acetylgalactosamin-
yltransferase is only functional with sialylated acceptors (14, 31) .
It is also interesting to note the cellular and tissue distribution of this enzyme .
Similar to the expression of the CT antigens, the activity of the fl,4-GaINAc
transferase is much higher in CTL clones than in T helper cell clones (32) .
Morever, the enzyme is found at high levels in the small intestine, where theCT
antigens are found on intraepithelial lymphocytes and the CT2 antigen is found
on the majority of intestinal epithelial cells (3, 4) . The enzyme is also detectable
in kidney extracts, while the CT2 but not theCT1 determinant is also found on
discrete structures within the kidney (Lefrancois, L., unpublisheddata) . Although
the precise differences between the CT 1 and CT2 determinants is not known,128
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the distribution of the ,Q1,4-GaINAc transferase and the results presented here
strongly suggest that this enzyme is involved in the formation of the oligosaccha-
ride moieties required for expression of both the CT1 and CT2 antigens.
A substrate for the #1,4-Ga1NAc transferase in the immune system is the T200
glycoprotein, which bears the CT determinants in CT' lymphocytes (1, 2, 5).
Furthermore, IL-2 can induce posttranslational modifications of the T200 gly-
coprotein resulting in the expression of the CT determinants on cytotoxic T
cells and thus may be regulating CT antigen expression at the level ofthis enzyme
(8, 33). In addition, recent results indicate that lymphocyte subset-specific expres-
sion of portions of the T200 protein occurs via variable usage of exons encoding
regions near the NHz-terminus oftheprotein (34-37). Theseregions are thought
to contain the majority of 0-linked glycans of T200 (35) and may be a second
level of regulation of CT determinant expression since CTL express a larger
T200 mRNA than T helper cells and CTL clones are CT' while T helper clones
are not (38).
A functional role for the CT determinants has yet to be demonstrated.
However, the restricted expression of these antigens suggest a possible role in
differentiation of lymphocyte subsets. During fetal development, high levels of
the CT antigens are present on nearly all early fetal thymocytes with a decrease
in the number of positive cells and a concomitant decrease in expression levels
of the CT antigens as birth approaches (5). The CT1 antigen is found only on a
subset of Lyt-2-,L3T4- fetal thymocytes while the CT2 antigen is expressed on
these cells as well as some Lyt-2+,L3T4+ fetal thymocytes. The only mature
peripheral T cells that have been found to express the CT antigens are a subset
of intraepithelial lymphocytes in the small intestine (3, 4). All of these cells are
Lyt-2+,L3T4- and a proportion are Thy-1-. We can speculate that the CT
determinants may play a role in the development of this branch of the mucosal
immune system, perhaps by influencing differentiation during thymus ontogeny
or by being involved in the homing of specific cells to the gut mucosa. Current
studies are centered around a functional assignment of the CT antigens and the
T200 glycoproteins.
Summary
The CT antigenic determinants have previously been shown to be present on
the T200 glycoproteins and other proteins of murine cytotoxic T cell clones but
not of T helper clones or nonactivated lymphocytes (1, 2). Two determinants
recognized by mAbs CT1 and CT2 are also expressed on thymocytes in a
developmentally regulated fashion during fetal thymus ontogeny and are found
in a subset of Lyt-2+ intraepithelial lymphocytes in the intestinal mucosa (3-5).
Previous studies of the biosynthesis of CT' proteins suggested that these deter-
minants were composed of carbohydrate (8). We now demonstrate that the anti-
CT mAbs react with a carbohydrate determinant at the nonreducing terminus
of 0-linked oligosaccharides that has the configuration Ga1NAc#1,4[SAa2,3]-
galactose. The CT antibodies detected this determinant not only on CTL clones
but also in the human blood group antigens Cad and Sda+. Variant CTL lines,
non-Cad erythrocytes, and Sda- glycoproteins that lacked the GaINAc residue
did not bind the CT mAb. Sialic acid was essential for CT antigen expressionsince neuraminidase or mild periodate treatment abrogated CT antibody bind-
ing. In addition, other carbohydrate structures with terminal GaINAc residues
such as the A or Tn blood group antigens were not recognized . The CT
antibodies thus define GaINAc and sialic acid containing carbohydrate antigens
that are expressed on discrete subsets of T lymphocytes and may also be useful
reagents for the detection ofCad and Sda+ blood group antigens .
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